Home Nucleus Pharmaceuticals RoMEA Influenza Drug Market to 2032

RoMEA Influenza Drug Market to 2032

Overview

The RoMEA Influenza Drug Market is expected to reach a 116.28 USD Million by 2032 and is projected to grow at a CAGR of 3.80% from 2025 to 2032.

Revenue, 2024 (USD Million)
90.87
Forecast, 2032 (USD Million)
116.28
CAGR, 2024 - 2032
3.80%
Report Coverage
RoMEA

RoMEA Influenza Drug Market 2018-2032 USD Million

RoMEA Influenza Drug Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 90.87 USD Million
  • Projected Market Size (2032): 116.28 USD Million
  • CAGR (2025-2032): 3.80%

Key Findings of RoMEA Influenza Drug Market

  • The RoMEA Influenza Drug Market was valued at 90.87 USD Million in 2024.
  • The RoMEA Influenza Drug Market is likely to grow at a CAGR of 3.80% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Vaccines in Treatment Segment accounted for the largest share of the market with a revenue of 157.07 USD Million
  • The fastest growing segment Oral in Route of Administration Segment grew Fastest with a CAGR of 4.67% during the forecast period from 2024 to 2032.

RoMEA Influenza Drug Market Scope

RoMEA Influenza Drug Market Segmentation & Scope
Treatment
  • Drugs
  • Vaccines
Route of Administration
  • Intravenous
  • Intranasal
  • Intradermal
  • Intramuscular
  • Oral
Age
  • Pediatrics
  • Adults
End User
  • Homecare
  • Hospitals
Distribution Channel
  • Retail Sales
  • Direct Tender
Type
  • Influenza C
  • Influenza B
  • Influenza A

RoMEA Influenza Drug Market Data Coverage Insights

Study Period 2024-2032
Base Year 2022
Unit Revenue in USD Million
Market Value in 2024 90.87 USD Million
Market Value in 2032 116.28 USD Million
CAGR (2025-2032) 3.80%
Historic Data 2016-2023
Market Segments Covered Treatment,Route of Administration,Age,End User,Distribution Channel,Type

Regional Insights:

  • Leading Market (2024-2032): RoMEA, leading in terms of revenue 90.87 USD Million in 2024
    • Key Country: RoMEA, leading in terms of revenue with value of 90.87 USD Million in 2024.

Segments and Scope

  • RoMEA Influenza Drug Market to 2032, By Treatment
    • Vaccines is the largest segment in RoMEA Influenza Drug Market to 2032 with a revenue of 157.07 USD Million in the year 2024.
    • Vaccines is the Fastest growing segment in RoMEA Influenza Drug Market to 2032 with a Growth rate of 3.82 % in forecast period 2025-2032.
  • RoMEA Influenza Drug Market to 2032, By Route of Administration
    • Oral is the largest segment in RoMEA Influenza Drug Market to 2032 with a revenue of 37.05 USD Million in the year 2024.
    • Oral is the Fastest growing segment in RoMEA Influenza Drug Market to 2032 with a Growth rate of 4.67 % in forecast period 2025-2032.
  • RoMEA Influenza Drug Market to 2032, By Age
    • Adults is the largest segment in RoMEA Influenza Drug Market to 2032 with a revenue of 47.29 USD Million in the year 2024.
    • Pediatrics is the Fastest growing segment in RoMEA Influenza Drug Market to 2032 with a Growth rate of 3.33 % in forecast period 2025-2032.
  • RoMEA Influenza Drug Market to 2032, By End User
    • Hospitals is the largest segment in RoMEA Influenza Drug Market to 2032 with a revenue of 64.68 USD Million in the year 2024.
    • Hospitals is the Fastest growing segment in RoMEA Influenza Drug Market to 2032 with a Growth rate of 3.98 % in forecast period 2025-2032.
  • RoMEA Influenza Drug Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in RoMEA Influenza Drug Market to 2032 with a revenue of 48.83 USD Million in the year 2024.
    • Direct Tender is the Fastest growing segment in RoMEA Influenza Drug Market to 2032 with a Growth rate of 4.16 % in forecast period 2025-2032.
  • RoMEA Influenza Drug Market to 2032, By Type
    • Influenza A is the largest segment in RoMEA Influenza Drug Market to 2032 with a revenue of 40.69 USD Million in the year 2024.
    • Influenza A is the Fastest growing segment in RoMEA Influenza Drug Market to 2032 with a Growth rate of 4.36 % in forecast period 2025-2032.

RoMEA Influenza Drug Market Company Share Analysis

 
Company Name Company Share Analysis
Sanofi
AstraZeneca
GSK plc.
CSL
F. Hoffmann-La Roche Ltd.
RoMEA Influenza Drug Market Company Share Analysis

RoMEA Influenza Drug Market Geographical Sales Distribution, 2018-2032 USD Million

RoMEA Influenza Drug Market Geographical Sales Distribution, 2018-2032 USD Million

RoMEA Influenza Drug Market Company Profiling

RoMEA Influenza Drug Market Company Profiling

Industry Related Reports

South America Cold Sore Treatment Market
Middle East & Africa Cold Sore Treatment Market
North America Cold Sore Treatment Market
Europe Cold Sore Treatment Market
Asia-Pacific Cold Sore Treatment Market
Argentina Cold Sore Treatment Market
Australia Cold Sore Treatment Market
Austria Cold Sore Treatment Market
Belgium Cold Sore Treatment Market
Brazil Cold Sore Treatment Market
Frequently Asked Questions
The RoMEA Influenza Drug Market is segmented based on Segmentation Treatment,Route of Administration,Age,End User,Distribution Channel,Type.
RoMEA Influenza Drug Market was valued at USD 90.87(Revenue in USD Million) in 2022.
RoMEA Influenza Drug Market is projected to grow at a CAGR of 3.80% during the forecast period of 2024 to 2032.
The Vaccines segment is expected to dominate the RoMEA Influenza Drug Market, holding a largest market share of 157.07 USD Million in 2024

RoMEA Influenza Drug Market Scope

RoMEA Influenza Drug Market Segmentation & Scope
Treatment
  • Drugs
  • Vaccines
Route of Administration
  • Intravenous
  • Intranasal
  • Intradermal
  • Intramuscular
  • Oral
Age
  • Pediatrics
  • Adults
End User
  • Homecare
  • Hospitals
Distribution Channel
  • Retail Sales
  • Direct Tender
Type
  • Influenza C
  • Influenza B
  • Influenza A
Frequently Asked Questions
The RoMEA Influenza Drug Market is segmented based on Segmentation Treatment,Route of Administration,Age,End User,Distribution Channel,Type.
RoMEA Influenza Drug Market was valued at USD 90.87(Revenue in USD Million) in 2022.
RoMEA Influenza Drug Market is projected to grow at a CAGR of 3.80% during the forecast period of 2024 to 2032.
The estimated market value of the RoMEA Influenza Drug Market for final year is USD 116.28 (USD Million).

RoMEA Influenza Drug Market Company Profiling

RoMEA Influenza Drug Market Company Profiling
Frequently Asked Questions
The RoMEA Influenza Drug Market is segmented based on Segmentation Treatment,Route of Administration,Age,End User,Distribution Channel,Type.
RoMEA Influenza Drug Market was valued at USD 90.87(Revenue in USD Million) in 2022.
RoMEA Influenza Drug Market is projected to grow at a CAGR of 3.80% during the forecast period of 2024 to 2032.
The estimated market value of the RoMEA Influenza Drug Market for final year is USD 116.28 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.

BROWSE RELATED PAGES